BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11

• Press Releases

  Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients

  March 9, 2026

   · 

  10 min read
• Press Releases

  Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

  March 9, 2026

   · 

  9 min read
• Press Releases

  Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis

  March 9, 2026

   · 

  5 min read
• Press Releases

  Tevogen Names Leadership Team to Execute Diversified Growth Strategy

  March 9, 2026

   · 

  5 min read
• Press Releases

  Data Published in Neurology and Therapy Demonstrate Significant Reductions in Relapse and MRI Activity with BRIUMVI® in People with Highly Active Relapsing Multiple Sclerosis

  March 9, 2026

   · 

  16 min read
• Press Releases

  ImmunityBio Announces Resubmission of Supplemental BLA to the FDA for ANKTIVA® Plus BCG in BCG-Unresponsive NMIBC with Papillary Disease Following Agency Review of Additional Data

  March 9, 2026

   · 

  11 min read
• Press Releases

  Candel Therapeutics To Present New Data after Extended Follow Up from Randomized Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

  March 9, 2026

   · 

  5 min read
• Press Releases

  Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

  March 9, 2026

   · 

  14 min read
• Press Releases

  Trevi Therapeutics Announces Completion of End-of-Phase 2 Meeting with the FDA, Gaining Alignment for Its Development Program for Idiopathic Pulmonary Fibrosis-Related Chronic Cough

  March 9, 2026

   · 

  6 min read
• Press Releases

  Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch

  March 9, 2026

   · 

  6 min read